Model
Edge
4D Molecular Therapeutics
0001920738
Filing Type
4
Filing Date
9/17/2024
Updated
9/18/24, 3:46 PM
Filing
4
Earnings Release
Exhibits
4
Statement of Changes in Beneficial Ownership